These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 32434490

  • 1. Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial.
    Li J, Chen Q, Wang J, Huang G, Ye H.
    BMC Pregnancy Childbirth; 2020 May 20; 20(1):310. PubMed ID: 32434490
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders.
    Skillern A, Leonard W, Pike J, Mak W.
    J Assist Reprod Genet; 2021 May 20; 38(5):1055-1060. PubMed ID: 33534048
    [Abstract] [Full Text] [Related]

  • 7. The Effect of GH Administration on Oocyte and Zygote Quality in Young Women With Repeated Implantation Failure After IVF.
    Tesarik J, Galán-Lázaro M, Conde-López C, Chiara-Rapisarda AM, Mendoza-Tesarik R.
    Front Endocrinol (Lausanne); 2020 May 20; 11():519572. PubMed ID: 33117271
    [Abstract] [Full Text] [Related]

  • 8. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.
    Hum Reprod; 2016 Feb 20; 31(2):370-6. PubMed ID: 26724797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence.
    Santiquet NW, Greene AF, Becker J, Barfield JP, Schoolcraft WB, Krisher RL.
    Mol Hum Reprod; 2017 Sep 01; 23(9):594-606. PubMed ID: 28586460
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis.
    Keane KN, Yovich JL, Hamidi A, Hinchliffe PM, Dhaliwal SS.
    BMJ Open; 2017 Oct 08; 7(10):e018107. PubMed ID: 28993395
    [Abstract] [Full Text] [Related]

  • 14. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S, Long H, Chang HY, Liu Y, Gao H, Zhu J, Quan X, Lyu Q, Kuang Y, Ai A.
    Hum Reprod; 2018 Feb 01; 33(2):229-237. PubMed ID: 29300975
    [Abstract] [Full Text] [Related]

  • 15. ICSI does not increase the cumulative live birth rate in non-male factor infertility.
    Li Z, Wang AY, Bowman M, Hammarberg K, Farquhar C, Johnson L, Safi N, Sullivan EA.
    Hum Reprod; 2018 Jul 01; 33(7):1322-1330. PubMed ID: 29897449
    [Abstract] [Full Text] [Related]

  • 16. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov 01; 48(11):838-42. PubMed ID: 24444561
    [Abstract] [Full Text] [Related]

  • 17. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S, Son WY, Gilman A, Younes G, Shavit T, Dahan MH.
    Hum Reprod; 2017 Jan 01; 32(1):119-124. PubMed ID: 27852688
    [Abstract] [Full Text] [Related]

  • 18. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study.
    Choe SA, Kim MJ, Lee HJ, Kim J, Chang EM, Kim JW, Park HM, Lyu SW, Lee WS, Yoon TK, Kim YS.
    Arch Gynecol Obstet; 2018 Mar 01; 297(3):791-796. PubMed ID: 29264647
    [Abstract] [Full Text] [Related]

  • 19. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL, Wang L, Lv F, Huang XM, Wang LP, Pan Y, Zhang XM.
    Medicine (Baltimore); 2017 Mar 01; 96(12):e6443. PubMed ID: 28328856
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K, Kogan I, Krikheli I, Dzhemlikhanova L, Muller V, Mekina I, Lesik E, Komarova E, Mazilina M, Niauri D, Gzgzyan A, Aylamazyan E.
    Gynecol Endocrinol; 2017 Mar 01; 33(sup1):15-17. PubMed ID: 29264990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.